Trogenix raised €80m in Series A led by IQ Capital, joined by 4Bio, Cancer Research Horizons, Brain Tumour Fund, Eli Lilly, Meltwind, LongeVC and Calculus
01 October 2025
01 October 2025
Total investments received (USD): 112.83M
Round value (USD): 93.84M
Company: Trogenix
Related deals
Chemify in a $50 million equity deal series B Extension backed by Zeon ventures from Japan
Investments
14 February 2026
Tenpoint Therapeutics raises $85M series B with Janus Henderson Investors, Hillhouse Investment, EQT and British Business Bank
Investments
30 January 2026
Beacon Tx raised $75m in Series C led by Goldman Sachs Alternatives, joined by the RD Fund, Syncona, Forbion, Oxford Science Enterprises, and Advent.
Investments
29 December 2025
Bit.bio raised $50m in Series C funding round led by M&G Investments.
Investments
29 December 2025
Chemify raised $50 million Series B round led by Insight Partners and Wing.
Investments
10 October 2025
Belgium
Austria
Denmark
Estonia
Finland
Iceland
Lithuania
Norway
Ireland
Italy
Portugal
Spain